These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12505328)

  • 21. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs.
    Patel J; Mitra AK
    Pharmacogenomics; 2001 Nov; 2(4):401-15. PubMed ID: 11722289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
    Gerloff T
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
    Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
    Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug metabolism and disposition in children.
    Strolin Benedetti M; Baltes EL
    Fundam Clin Pharmacol; 2003 Jun; 17(3):281-99. PubMed ID: 12803568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of transport proteins in drug absorption, distribution and excretion.
    Ayrton A; Morgan P
    Xenobiotica; 2001; 31(8-9):469-97. PubMed ID: 11569523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues.
    Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D
    Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of transporters in toxicity and disease.
    Schuetz JD; Swaan PW; Tweedie DJ
    Drug Metab Dispos; 2014 Apr; 42(4):541-5. PubMed ID: 24598705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of P-glycoprotein in drug disposition.
    Tanigawara Y
    Ther Drug Monit; 2000 Feb; 22(1):137-40. PubMed ID: 10688277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences.
    Awasthi S; Cheng JZ; Singhal SS; Pandya U; Sharma R; Singh SV; Zimniak P; Awasthi YC
    Biochemistry; 2001 Apr; 40(13):4159-68. PubMed ID: 11300797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transporters in absorption, distribution, and elimination.
    Scherrmann JM
    Chem Biodivers; 2009 Nov; 6(11):1933-42. PubMed ID: 19937831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.
    Liddle C; Goodwin B
    Semin Liver Dis; 2002; 22(2):115-22. PubMed ID: 12016543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
    Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid transporters: structure, function, regulation and pathophysiological implications.
    Alrefai WA; Gill RK
    Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian ABC transporters in health and disease.
    Borst P; Elferink RO
    Annu Rev Biochem; 2002; 71():537-92. PubMed ID: 12045106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.